Drug intelligence / Profile preview

Algorex

Development stage
Unknown
Lead developer
Amnol
Modality
Small Molecules, Recombinant Proteins and Enzymes
Administration
Topical, Oral
01

Overview

Algorex is a therapeutic product line developed by Amnol Chimica Biologica, specifically indicated for phlebological conditions such as chronic venous insufficiency, heavy legs, and localized edema. The formulation is available as a topical cream and an oral supplement. The cream typically contains a synergistic blend of escin, bromelain, Boswellia serrata, and heparin sodium. Escin, a triterpene saponin from horse chestnut, acts as a vasoprotective agent by decreasing capillary permeability and increasing venous tone. Bromelain is a proteolytic enzyme that aids in the breakdown of fibrin and the reduction of inflammatory edema. Boswellia serrata extract provides anti-inflammatory effects by inhibiting the 5-lipoxygenase (5-LOX) enzyme, thereby reducing the production of pro-inflammatory leukotrienes. Heparin sodium provides localized anticoagulant effects, assisting in the resolution of micro-clots and hematomas. Together, these ingredients provide a synergistic approach to treating heavy legs, edema, and venous congestion.

Brand names
Algorex
Other names
Algorex cremaAlgorex compresse
02

Targets

ATIII (Antithrombin III)ALOX5 (Arachidonate 5-lipoxygenase)HYAL (Hyaluronidase family (HYAL))Fibrin (Factor Ia)

Beyond the preview

Go deeper on Algorex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Algorex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call